GLP-1s stimulate the production of insulin to reduce blood sugar, slow the digestion process, reduce appetite, and signal fullness
8 GLP-1 medications also delay gastric emptying
While the exact mechanism remains unclear, this reduction could be tied to weight loss, visceral fat reduction, improved glucose control, or potentially an independent anti-inflammatory effect
Functional receptors for glucagon-like peptide-1-(7-36)amide on a somatostatin secreting cell line
Several biological pathways have been proposed, though the evidence in humans remains limited for many of these hypotheses
Available evidence comes from ingredient studies rather than the complete formulation